GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,000 | +29.6% | 521 | -36.2% | 0.00% | – |
| Q2 2022 | $27,000 | -43.8% | 817 | -41.3% | 0.00% | – |
| Q1 2022 | $48,000 | -12.7% | 1,392 | -25.4% | 0.00% | – |
| Q4 2021 | $55,000 | +52.8% | 1,865 | +31.8% | 0.00% | – |
| Q3 2021 | $36,000 | -71.9% | 1,415 | -61.4% | 0.00% | – |
| Q2 2021 | $128,000 | -6.6% | 3,664 | +8.9% | 0.00% | – |
| Q1 2021 | $137,000 | +93.0% | 3,366 | +106.2% | 0.00% | – |
| Q4 2020 | $71,000 | +57.8% | 1,632 | +107.6% | 0.00% | – |
| Q3 2020 | $45,000 | -66.9% | 786 | -63.2% | 0.00% | – |
| Q2 2020 | $136,000 | -11.7% | 2,134 | -70.0% | 0.00% | -100.0% |
| Q1 2020 | $154,000 | – | 7,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |